• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Clinical features and disease severity in an Iranian population of inpatients with COVID-19

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Apr 22;11(1):8731.
doi: 10.1038/s41598-021-87917-1.
Clinical features and disease severity in an Iranian population of inpatients with COVID-19


Shima Nabavi[SUP] 1 [/SUP], Zahra Javidarabshahi[SUP] 2 [/SUP], Abolghasem Allahyari[SUP] 3 [/SUP], Mohammad Ramezani[SUP] 4 [/SUP], Mohsen Seddigh-Shamsi[SUP] 3 [/SUP], Sahar Ravanshad[SUP] 1 [/SUP], Mina AkbariRad[SUP] 1 [/SUP], Farnoosh Ebrahimzadeh[SUP] 1 [/SUP], Shohre Khatami[SUP] 1 [/SUP], Maryam Emadzadeh[SUP] 5 [/SUP], Neda Saeedian[SUP] 1 [/SUP], Ahmadreza Zarifian[SUP] 5 [/SUP], Maryam Miri[SUP] 6 [/SUP], Fariba Rezaeetalab[SUP] 2 [/SUP], Sepide Hejazi[SUP] 2 [/SUP], Reza Basiri[SUP] 2 [/SUP], Mahnaz Mozdourian[SUP] 7 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) can present with a variety of symptoms. Severity of the disease may be associated with several factors. Here, we review clinical features of COVID-19 inpatients with different severities. This cross-sectional study was performed in Imam Reza hospital, Mashhad, Iran, during February-April 2020. COVID-19 patients with typical computed tomography (CT) patterns and/or positive reverse-transcriptase polymerase chain reaction (RT-PCR) were included. The patients were classified into three groups of moderate, severe, and critical based on disease severity. Demographic, clinical, laboratory, and radiologic findings were collected and compared. P < 0.05 was considered statistically significant. Overall, 200 patients with mean age of 69.75 ? 6.39 years, of whom 82 (41%) were female were studied. Disease was severe/critical in the majority of patients (167, 83.5%). Disease severity was significantly associated with age, malignant comorbidities, dyspnea, nausea/vomiting, confusion, respiratory rate, pulse rate, O[SUB]2[/SUB] saturation, extent of CT involvement, serum C-reactive protein (CRP), pH, pO[SUB]2[/SUB], and aspartate transaminase (P < 0.05). Moreover, complications including shock, coagulopathy, acidosis, sepsis, acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission, and intubation were significantly higher in patients with higher severities (P < 0.05). O[SUB]2[/SUB] saturation, nausea/vomiting, and extent of lung CT involvement were independent predictors of severe/critical COVID-19 (OR 0.342, 45.93, and 25.48, respectively; P < 0.05). Our results indicate O[SUB]2[/SUB] saturation, nausea/vomiting, and extent of lung CT involvement as independent predictors of severe COVID-19 conditions. Serum CRP levels and pO[SUB]2[/SUB] were also considerably higher patients with higher severity and can be used along with other factors to predict severe disease in COVID-19 patients.
 
Back
Top Bottom